SHUANGCHENG FDA Approval ANDA 210165

ANDA 210165

SHUANGCHENG

FDA Drug Application

Application #210165

Application Sponsors

ANDA 210165SHUANGCHENG

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORALEQ 15MG BASE0PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDE
002TABLET;ORALEQ 30MG BASE0PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDE
003TABLET;ORALEQ 45MG BASE0PIOGLITAZONE HYDROCHLORIDEPIOGLITAZONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-01-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

SHUANGCHENG
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210165
            [companyName] => SHUANGCHENG
            [docInserts] => ["",""]
            [products] => [{"drugName":"PIOGLITAZONE HYDROCHLORIDE","activeIngredients":"PIOGLITAZONE HYDROCHLORIDE","strength":"EQ 15MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PIOGLITAZONE HYDROCHLORIDE","activeIngredients":"PIOGLITAZONE HYDROCHLORIDE","strength":"EQ 30MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PIOGLITAZONE HYDROCHLORIDE","activeIngredients":"PIOGLITAZONE HYDROCHLORIDE","strength":"EQ 45MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/22\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-01-22
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.